Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden setting
B. Bernshtein, M. Kelly, D. Cizmeci, J. A. Zhiteneva, R. Macvicar, M. Kamruzzaman, T. R. Bhuiyan, F. Chowdhury, A. I. Khan, F. Qadri, R. C. Charles, P. Xu, P. Kovac, R. W. Kaminski, G. Alter, E. T. Ryan
Abstract
Shigella is the second leading cause of diarrheal disease-related death in young children in low and middle income countries. The mechanism of protection against shigella infection and disease in endemic areas is uncertain. While historically LPS-specific IgG titers have been associated with protection in endemic settings, emerging deeper immune approaches have recently elucidated a protective role for IpaB-specific antibody responses in a controlled human challenge model in North American volunteers. To deeply interrogate potential correlates of immunity in areas endemic for shigellosis, here we applied a systems approach to analyze the serological response to shigella across endemic and non-endemic populations. Additionally, we analyzed shigella-specific antibody responses over time in the context of endemic resistance or breakthrough infections in a high shigella burden location. Individuals with endemic exposure to shigella possessed broad and functional antibody responses across both glycolipid and protein antigens compared to individuals from non-endemic regions. In high shigella burden settings, elevated levels of OSP-specific FcR binding antibodies were associated with resistance to shigellosis. OSP-specific FcR binding IgA found in resistant individuals activated bactericidal neutrophil functions including phagocytosis, degranulation and reactive oxygen species production. Moreover, IgA depletion from resistant serum significantly reduced binding of OSP-specific antibodies to FcR and antibody mediated activation of neutrophils and monocytes. Overall, our findings suggest that OSP-specific functional IgA responses contribute to protective immunity against shigella infection in high-burden settings. These findings will assist in the development and evaluation of shigella vaccines.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Limited O-specific polysaccharide (OSP)-specific functional antibody responses in young children with Shigella infection in Bangladesh
Biana Bernshtein, Julia A. Zhiteneva, … Edward Thomas Ryan·Cell Reports MedicinePeer-reviewed·Sep 24, 2026
- Repertoire of naturally acquired maternal antibodies transferred to infants for protection against shigellosis
E. Ndungo, L. R. Andronescu, … M. F. Pasetti·Frontiers in ImmunologyPeer-reviewed·Oct 15, 2021
- Protective and pathogenic antibody responses from a primate Shigella outbreak inform vaccine design
Robert M. Gallant, Paul Savarino, … Hayden R. Schmidt·bioRxiv·Dec 19, 2025
- Mechanisms of mucosal immunity to oral Shigella infection in a physiological mouse model
Janet Peace Babirye, Emma F. Lackner, … Russell E. Vance·bioRxiv·Sep 14, 2026
- Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence
V. Torraca, M. Kaforou, … S. Mostowy·PLOS PathogensPeer-reviewed·Dec 12, 2019
- Outer membrane vesicles derived from Salmonella Typhimurium can deliver Shigella flexneri 2a O-polysaccharide antigen to prevent lethal pulmonary infection in mice